Cargando...
First Trust NYSE Arca Biotechnology Index Fund (FBT)
Sector Equity · Estados Unidos
Posiciones
Las 31 mayores posiciones de FBT de 30 en total, a 2026-09-08. La cartera es del fondo, no de esta línea concreta: es la misma en todos los mercados donde cotiza.
Peso de las mostradas
100%
En compañías con ficha
99,89%
Posiciones del fondo
30
| # | Posición | Peso |
|---|---|---|
| 1 | Halozyme Therapeutics, Inc.HALO | 4,43% |
| 2 | Regeneron Pharmaceuticals, Inc.REGN | 3,82% |
| 3 | NeoGenomics, Inc.NEO | 3,78% |
| 4 | Natera, Inc.NTRA | 3,73% |
| 5 | Corcept Therapeutics Inc.CORT | 3,72% |
| 6 | Amgen Inc.AMGN | 3,69% |
| 7 | BeOne Medicines Ltd. (ADR)ONC | 3,68% |
| 8 | Sarepta Therapeutics, Inc.SRPT | 3,64% |
| 9 | argenx SE (ADR)ARGX | 3,61% |
| 10 | Gilead Sciences, Inc.GILD | 3,56% |
| 11 | Repligen CorporationRGEN | 3,56% |
| 12 | Genmab A/S (ADR)GMAB | 3,55% |
| 13 | Illumina, Inc.ILMN | 3,52% |
| 14 | BioNTech SE (ADR)BNTX | 3,48% |
| 15 | BioMarin Pharmaceutical Inc.BMRN | 3,45% |
| 16 | Vertex Pharmaceuticals IncorporatedVRTX | 3,45% |
| 17 | Biogen Inc.BIIB | 3,4% |
| 18 | Incyte CorporationINCY | 3,33% |
| 19 | ADMA Biologics, Inc.ADMA | 3,25% |
| 20 | Exelixis, Inc.EXEL | 3,2% |
| 21 | Bio-Techne CorporationTECH | 3,11% |
| 22 | Madrigal Pharmaceuticals, Inc.MDGL | 3,09% |
| 23 | TG Therapeutics, Inc.TGTX | 3% |
| 24 | Bruker CorporationBRKR | 2,99% |
| 25 | United Therapeutics CorporationUTHR | 2,73% |
| 26 | Alnylam Pharmaceuticals, Inc.ALNY | 2,73% |
| 27 | Alkermes PlcALKS | 2,72% |
| 28 | Axsome Therapeutics, Inc.AXSM | 2,71% |
| 29 | Neurocrine Biosciences, Inc.NBIX | 2,69% |
| 30 | Veracyte, Inc.VCYT | 2,29% |
| 31 | US Dollar | 0,11% |
Las posiciones subrayadas llevan a su ficha: son compañías que cubrimos con datos propios.